Human Equilibrative Nucleoside Transporters 1 and 2 may be Differentially Modulated by A2B Adenosine Receptors in Placenta Microvascular Endothelial Cells from Pre-eclampsia

Placenta

Volumn 29, Issue 9, 2008, Pages 816-825

  Escudero, C ^a   Casanello, P ^a   Sobrevia, L ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adenosine; Endothelium; Human; Placenta; Pre eclampsia

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FETUS BLOOD; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MALE; NEWBORN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOSINE; ADULT; ENDOTHELIAL CELLS; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2; FEMALE; GENE EXPRESSION REGULATION; HUMANS; PHENETHYLAMINES; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; TRIAZINES; TRIAZOLES;

EID: 50249099855     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.06.014     Document Type: Article

References (47)

1. Redman C.W. Current topic: pre-eclampsia and the placenta. Placenta 12 (1991) 301-308
2. Granger J.P., Alexander B.T., Llinas M.T., Bennett W.A., and Khalil R.A. Pathophysiology of preeclampsia: linking placental. Microcirculation 9 (2002) 147-160
3. Baumwell S., and Karumanchi S.A. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract 106 (2007) c72-c81
4. Terán E., Escudero C., Vivero S., Enríquez A., and Calle A. Hypertens Pregnancy. Intraplatelet cyclic guanosine-3′,5′-monophosphate levels during pregnancy and preeclampsia 23 (2004) 303-308
5. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqeel H., et al. World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. Am J Obstet Gynecol 194 (2006) 921-931
6. Casanello P., Escudero C., and Sobrevia L. Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: implications in foetal endothelial dysfunction in human pregnancy diseases. Curr Vasc Pharmacol 5 (2007) 69-84
7. Di Paolo S., Volpe P., Grandaliano G., Stallone G., Schena A., Greco P., et al. Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol 16 (2003) 650-657
8. Wareing M., and Baker P.N. Vasoconstriction of small arteries isolated from the human placental chorionic plate in normal and compromised pregnancy. Hypertens Pregnancy 23 (2004) 237-246
9. Egbor M., Ansari T., Morris N., Green C.J., and Sibbons P.D. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. Br J Gynaecol 113 (2006) 580-589
10. Marzioni D., Tamagnone L., Capparuccia L., Marchini C., Amici A., Todros T., et al. Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A. Dev Dyn 231 (2004) 839-848
11. Carbillon L., Uzan M., and Uzan S. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv 55 (2000) 574-581
12. Vásquez G., Sanhueza F., Vásquez R., González M., San Martín R., Casanello P., et al. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J Physiol 560 (2004) 111-122
13. Yoneyama Y., Suzuki S., Sawa R., Yoneyama K., Power G.G., and Araki T. Increased plasma adenosine concentrations and the severity of preeclampsia. Obstet Gynecol 100 (2002) 1266-1270
14. Yoneyama Y., Sawa R., Suzuki S., Shin S., Power G.G., and Araki T. The relationship between uterine artery Doppler velocimetry and umbilical venous adenosine levels in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 174 (1996) 267-271
15. Baldwin S.A., Beal P.R., Yao S.Y., King A.E., Cass C.E., and Young J.D. The equilibrative nucleoside transporter family, SLC29. Pflügers Arch 447 (2004) 735-743
16. Burnstock G. Purinergic signalling. Br J Pharmacol 147 (2006) S172-S181
17. San Martín R., and Sobrevia L. Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta 27 (2006) 1-10
18. Kurpis L., John D., and Fox I.H. Evidence for an adenosine receptor in human tissues. Adv Exp Med Biol 165 (1984) 497-500
19. Schocken D.D., and Schneider M.N. Use of multiple radioligands to characterize adenosine receptors in human placenta. Placenta 7 (1986) 339-348
20. Read M.A., Boura A.L., and Walters W.A. Vascular actions of purines in the foetal circulation of the human placenta. Br J Pharmacol 110 (1993) 454-460
21. Puffinbarger N.K., Hansen K.R., Resta R., Laurent A.B., Knudsen T.B., Madara J.L., et al. Production and characterization of multiple antigenic peptide antibodies to the adenosine A2b receptor. Mol Pharmacol 47 (1995) 1126-1132
22. 2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade. Am J Physiol Heart Circ Physiol 288 (2005) H2439-H2449
23. Jennings L.L., Hao C., Cabrita M.A., Vickers M.F., Baldwin S.A., Young J.D., et al. Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system. Neuropharmacology 40 (2001) 722-731
24. Sawynok J., Reid A.R., Liu X.J., and Parkinson F.E. Amitriptyline enhances extracellular tissue levels of adenosine in the rat hindpaw and inhibits adenosine uptake. Eur J Pharmacol 518 (2005) 116-122
25. 2A receptors control the extracellular levels of adenosine through modulation of nucleoside transporters activity in the rat hippocampus. J Neurochem 93 (2005) 595-604
26. Lang I., Pabst M.A., Hiden U., Blaschitz A., Dohr G., Hahn T., et al. Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. Eur J Cell Biol 82 (2003) 163-173
27. Dye J.F., Vause S., Johnston T., Clark P., Firth J.A., D'Souza S.W., et al. Characterization of cationic amino acid transporters and expression of endothelial nitric oxide synthase in human placental microvascular endothelial cells. FASEB J 18 (2004) 125-127
28. Casanello P., Torres A., Sanhueza F., González M., Farías M., Gallardo V., et al. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ Res 97 (2005) 16-24
29. Görlach A. Control of adenosine transport by hypoxia. Circ Res 97 (2005) 1-3
30. Radaelli T., Cetin I., Ayuk P.T., Glazier J.D., Pardi G., and Sibley C.P. Cationic amino acid transporter activity in the syncytiotrophoblast microvillous plasma membrane and oxygenation of the uteroplacental unit. Placenta 23 (2002) S69-S74
31. Aguayo C., Casado J., Gonzalez M., Pearson J.D., Martin R.S., Casanello P., et al. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia. Placenta 26 (2005) 641-653
32. Griffith D.A., and Jarvis S.M. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286 (1996) 153-181
33. Devés R., and Boyd C.A. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78 (1998) 487-545
34. Ongini E., Dionisotti S., Gessi S., Irenius E., and Fredholm B.B. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 359 (1999) 7-10
35. Desai A., Victor-Vega C., Gadangi S., Montesinos M.C., Chu C.C., and Cronstein B.N. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol Pharmacol 67 (2005) 1406-1413
36. Fredholm B.B., IJzerman A.P., Jacobson K.A., Klotz K.N., and Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53 (2001) 527-552
37. Wyatt A.W., Steinert J.R., Wheeler-Jones C.P., Morgan A.J., Sugden D., Pearson J.D., et al. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 16 (2002) 1584-1594
38. Farías M., San Martín R., Puebla C., Pearson J.D., Casado J.F., Pastor-Anglada M., et al. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human foetal endothelium from gestational diabetes. J Cell Physiol 208 (2006) 451-460
39. Puebla C., Farías M., González M., Vecchiola A., Aguayo C., Krause B., et al. High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium. J Cell Physiol 215 (2008) 645-656
40. 1 receptors in modulating extracellular adenosine levels. J Pharmacol Exp Ther 291 (1999) 76-80
41. Roberts J.M., and Gammill H.S. Preeclampsia: recent insights. Hypertension 46 (2005) 1243-1249
42. Takeuchi T., Yoneyama Y., Suzuki S., Sawa R., Otsubo Y., and Araki T. Regulation of platelet aggregation in vitro by plasma adenosine in preeclampsia. Gynecol Obstet Invest 51 (2001) 36-39
43. Escudero C., and Sobrevia L. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 29 (2008) 469-483
44. Bijlstra P., van Ginneken E.E., Huls M., van Dijk R., Smits P., and Rongen G.A. Glyburide inhibits dipyridamole-induced forearm vasodilation but not adenosine-induced forearm vasodilation. Clin Pharmacol Ther 75 (2004) 147-156
45. Marshall J.M. The roles of adenosine and related substances in exercise hyperaemia. J Physiol 583 (2007) 835-845
46. Hyde R.J., Cass C.E., Young J.D., and Baldwin S.A. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18 (2001) 53-63
47. Pastor-Anglada M., Casado F.J., Valdés R., Mata J., García-Manteiga J., and Molina M. Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Membr Biol 18 (2001) 81-85